A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer
Clinical trial NCT05896566 · COMPLETED
Trial details
- NCT number
- NCT05896566
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-23
- Primary completion
- 2025-09-18
- Enrollment
- 231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.